Group items tagged

This report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity.

Interesting info. What other meds can be taken?

As far as I know, Xenical (Orlistat) promotes weight loss by decreasing the amount of dietary fat absorbed in your intestines. You can find out more about it on the Canada Drugs site https://www.canadadrugsdirect.com/. It has to be noted, that this medication should only be used under the supervision of a trained healthcare professional.

Social media marketing has gained increased focus, and retail banks are changing their business models and product offerings to cater to the ballooning market of social media users. The increasing prevalence of the internet and widespread adoption of smartphones have fuelled social media expansion, with more than half the internet population now engaged in social networking. Although the use of social media remains risky territory for many banks, some have started to explore opportunities in this channel. However, despite initial skepticism by retail banks, social media is expected to emerge as a key complimentary channel for business development. Banks are expected to focus more on synergies that can be generated by social media and other key channels over the next five years.

The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Elemental information and data relating to the clinical trials on fatty liver disease including an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe offers a perspective on the fatty liver disease clinical trial scenario. Disease clinical trials by their phase, trial status, prominence of the sponsors pertaining to the number of trials for the key drugs for treating fatty liver disease hints at the dynamics of a particular indication in a condensed manner in addition to the commercial landscape of the major universities, institutes, hospitals or companies.